Cristina Fernandez Turienzo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Cristina Fernandez Turienzo has a total of 185 co-authors. Here are the top co-authors by number of shared publications:
- Jane Sandall
Department of Women and Children's Health, King's College London, United Kingdom
14 shared publications Jane Sandall
10 shared publications- Paul Townsend Seed
Department of Women and Children's Health, King's College London, London, UK
7 shared publications - Hannah Rayment-Jones
Department of Women and Children's Health, King's College London, United Kingdom
6 shared publications Lucy November
Department of Women & Children’s Health, School of Life Course & Population Health Sciences, Faculty of Life Sciences & Medicine, King’s College London, London, UK
6 shared publicationsMangenda Kamara
University of Sierra Leone, Freetown, Sierra Leone
6 shared publications
Latest Publications
- Open Access
- 9 November 2026
- Published by Elsevier in eClinicalMedicine
- Vol. 101
Interventions to prevent suicide and suicidal thoughts or behaviours in the perinatal period: a global mixed-methods systematic review
- 9 November 2026
- Published by Elsevier in eClinicalMedicine
- Vol. 101
Open AccessInterventions to prevent suicide and suicidal thoughts or behaviours in the perinatal period: a global mixed-methods systematic review
- Open Access
- 11 August 2026
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 68
Making the invisible visible: maternal and child health inequalities for Latin Americans in the UK
- 11 August 2026
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 68
Open AccessMaking the invisible visible: maternal and child health inequalities for Latin Americans in the UK
- Open Access
- 15 June 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (6) , e023974
Gi4SaveLife: a community-led model for sustainable voluntary blood donation in rural Sierra Leone
Sierra Leone faces critical blood shortages reliant on family replacement and paid donors, contributing to high maternal mortality. Traditional top-down blood drives have failed to build sustainable voluntary donor bases due to mistrust and logistical barriers. We developed 'Gi4SaveLife’, a community-led model to foster local ownership and sustainable donation. Implemented in Kono and Kenema districts, this quality improvement initiative established community 'hubs’ led by local volunteers responsible for peer-to-peer education and mobilisation. We conducted a baseline survey to identify barriers, followed by monthly blood drives using non-monetary incentives. Data on collection volumes, donor demographics and costs were tracked over 8 months. The initiative collected 539 units from 376 unique donors, moving from zero voluntary donations at baseline to a consistent supply. Crucially, 43% (161) were repeat donations, indicating a committed donor pool. The cost per unit decreased by 40% compared with standard NGO-led models. Key motivators included altruism (71%) and social recognition (52%). Gi4SaveLife demonstrates that a community-led approach, grounded in ownership and trust, can establish a cost-effective, sustainable pipeline of voluntary donors in low-resource settings. This model offers a scalable framework to bolster national blood transfusion services by bridging the gap between communities and health facilities.
- 15 June 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (6) , e023974
Open AccessGi4SaveLife: a community-led model for sustainable voluntary blood donation in rural Sierra Leone
Sierra Leone faces critical blood shortages reliant on family replacement and paid donors, contributing to high maternal mortality. Traditional top-down blood drives have failed to build sustainable voluntary donor bases due to mistrust and logistical barriers. We developed 'Gi4SaveLife’, a community-led model to foster local ownership and sustainable donation. Implemented in Kono and Kenema districts, this quality improvement initiative established community 'hubs’ led by local volunteers responsible for peer-to-peer education and mobilisation. We conducted a baseline survey to identify barriers, followed by monthly blood drives using non-monetary incentives. Data on collection volumes, donor demographics and costs were tracked over 8 months. The initiative collected 539 units from 376 unique donors, moving from zero voluntary donations at baseline to a consistent supply. Crucially, 43% (161) were repeat donations, indicating a committed donor pool. The cost per unit decreased by 40% compared with standard NGO-led models. Key motivators included altruism (71%) and social recognition (52%). Gi4SaveLife demonstrates that a community-led approach, grounded in ownership and trust, can establish a cost-effective, sustainable pipeline of voluntary donors in low-resource settings. This model offers a scalable framework to bolster national blood transfusion services by bridging the gap between communities and health facilities.
- Open Access
Barriers to healthcare access during pregnancy and after birth for adolescent girls living with disability in Sierra Leone: a qualitative study
Background and objective In 2017, Lifeline Nehemiah Projects in Sierra Leone launched 2YoungLives, a mentoring initiative for vulnerable pregnant adolescents, including those living with disabilities. Drawing from the social model of disability, we aimed to investigate the exacerbated disabling barriers which prevent these girls and their babies from accessing available healthcare and develop comprehensive solutions to improve their access. Design Qualitative methods were used in this study. Setting Participants were invited to participate in face-to-face interviews in one district in Sierra Leone. Participants Six pregnant or postnatal adolescents living with disability, alongside four caregivers and five stakeholders from various organisations participated in semi-structured interviews employing thematic analysis. Results We identified four key themes: (1) discrimination and financial barriers within the healthcare system, despite laws ensuring free healthcare for persons living with disabilities, (2) societal stigma manifested through abandonment by families and inadequate support, (3) lack of understanding of disability issues, particularly of those with intellectual impairments, leading to stigmatisation and exclusion, and (4) infrastructural limitations which hinder accessibility to essential services, with many facilities remaining non-compliant with disability regulations. Conclusion Adolescent girls living with disability during pregnancy and after birth in Sierra Leone face barriers to accessing healthcare, including caregiver ignorance, lack of autonomy, disabling services, social stigma and ineffective policy implementation, despite existing supportive laws. These findings keep those women who are arguably the most vulnerable, adolescent and living with a disability, from accessing perinatal healthcare, exacerbating their risk and that of their babies. Solutions include the need to enforce disability-inclusive policies and infrastructure adaptations, awareness and training for healthcare providers and community advocacy to break down social stigma.
Open AccessBarriers to healthcare access during pregnancy and after birth for adolescent girls living with disability in Sierra Leone: a qualitative study
Background and objective In 2017, Lifeline Nehemiah Projects in Sierra Leone launched 2YoungLives, a mentoring initiative for vulnerable pregnant adolescents, including those living with disabilities. Drawing from the social model of disability, we aimed to investigate the exacerbated disabling barriers which prevent these girls and their babies from accessing available healthcare and develop comprehensive solutions to improve their access. Design Qualitative methods were used in this study. Setting Participants were invited to participate in face-to-face interviews in one district in Sierra Leone. Participants Six pregnant or postnatal adolescents living with disability, alongside four caregivers and five stakeholders from various organisations participated in semi-structured interviews employing thematic analysis. Results We identified four key themes: (1) discrimination and financial barriers within the healthcare system, despite laws ensuring free healthcare for persons living with disabilities, (2) societal stigma manifested through abandonment by families and inadequate support, (3) lack of understanding of disability issues, particularly of those with intellectual impairments, leading to stigmatisation and exclusion, and (4) infrastructural limitations which hinder accessibility to essential services, with many facilities remaining non-compliant with disability regulations. Conclusion Adolescent girls living with disability during pregnancy and after birth in Sierra Leone face barriers to accessing healthcare, including caregiver ignorance, lack of autonomy, disabling services, social stigma and ineffective policy implementation, despite existing supportive laws. These findings keep those women who are arguably the most vulnerable, adolescent and living with a disability, from accessing perinatal healthcare, exacerbating their risk and that of their babies. Solutions include the need to enforce disability-inclusive policies and infrastructure adaptations, awareness and training for healthcare providers and community advocacy to break down social stigma.
- Open Access
- 2 June 2026
- Published by International Society of Global Health in Journal of Global Health
- Vol. 16, 04135
A global scoping review of community-based mentoring interventions for adolescent girls during pregnancy and after birth
The latest Lancet series on optimising child and adolescent health and development highlights the need to support a holistic agenda to improve the integration and implementation of evidence-based interventions across health, education, and social systems to protect, nurture, and support the health and developmental potential of every child and adolescent [1]. In addition to health […]
- 2 June 2026
- Published by International Society of Global Health in Journal of Global Health
- Vol. 16, 04135
Open AccessA global scoping review of community-based mentoring interventions for adolescent girls during pregnancy and after birth
The latest Lancet series on optimising child and adolescent health and development highlights the need to support a holistic agenda to improve the integration and implementation of evidence-based interventions across health, education, and social systems to protect, nurture, and support the health and developmental potential of every child and adolescent [1]. In addition to health […]
- 21 May 2026
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2026 (5) , CD009273
Planned early birth versus expectant management for hypertensive disorders from 34 weeks' gestation to term
Hypertensive disorders in pregnancy are significant contributors to maternal and perinatal morbidity and mortality. They include chronic hypertension, gestational hypertension and pre-eclampsia. Definitive management of these disorders is planned early birth. The alternative is expectant management with close monitoring, if severe complications are not present. There are benefits and risks associated with both policies, so it is important to establish the safest option. To assess the benefits and risks of planned early birth versus expectant management in pregnant women with hypertensive disorders, from 34 weeks' gestation onwards. An Information Specialist within the Cochrane Central Executive Team searched CENTRAL, MEDLINE, Embase, CINAHL, ClinicalTrials.gov and WHO ICTRP. The searches were run from 1 January 2016 to 16 January 2026 with no language restrictions. Reference lists of retrieved studies were also searched. We included randomised controlled trials comparing planned early birth (by induction of labour or by caesarean section) with expectant management for women with hypertensive disorders from 34 weeks' gestation. Cluster-randomised trials would have been eligible for inclusion in this review, but we found none. Studies using a quasi-randomised design were not eligible for inclusion in this review. Studies using a cross-over design were not eligible for inclusion, because they are not a suitable study design for investigating hypertensive disorders in pregnancy. The prespecified critical outcomes (based upon a core outcome set agreed via Delphi consensus) were (1) a composite outcome of maternal mortality and morbidity; (2) a composite outcome of perinatal mortality and morbidity; (3) maternal death; (4) fetal death; (5) neonatal death. The prespecified important maternal outcomes were: caesarean section, maternal admission to a high dependency unit, eclampsia, pulmonary oedema, severe renal impairment, and HELLP (haemolysis, elevated liver enzymes, low platelets) syndrome. The prespecified important perinatal outcome was neonatal unit admission. Additional maternal and perinatal outcomes were also analysed in accordance with the review protocol, including maternal quality of life measures and health resource use. Two review authors independently assessed risk of bias using the Cochrane Risk of Bias 2 (RoB 2) tool. The Cochrane trustworthiness screening tool was applied to all eligible studies at full-text review stage. Two review authors independently assessed eligibility and risk of bias. Two review authors independently extracted data using a prespecified data extraction form. Data were checked for accuracy. Statistical analysis was carried out in RevMan using a random-effects meta-analysis. We assessed the certainty of evidence using GRADE. We included six studies involving 3491 women. All six studies were randomised controlled trials evaluating planned early birth compared to expectant management. Planned early birth was evaluated at between 34 and 37 weeks in four studies, between 36 and 38 weeks in one study and between 36 and 41 weeks in one study. One study took place in low- and middle-income countries, whilst five took place in high-income countries. Three studies included only women with pre-eclampsia, two studies included women with a mixture of hypertensive disorders in pregnancy and one study included only women with chronic hypertension. Planned early birth reduces the risk of maternal mortality and morbidity compared to expectant management (RR 0.54, 95% CI 0.37 to 0.77; I² = 0%; 6 studies, 3491 participants; high-certainty evidence). There was no increased risk of caesarean section associated with planned early birth (RR 0.94, 95% CI 0.83 to 1.06; I² = 25%; 6 studies, 3539 participants; high-certainty evidence). Planned early birth likely results in a large reduction in the risk of stillbirth (fetal death) (RR 0.25, 95% CI 0.07 to 0.87; I² not applicable; 5 studies, 3407 participants; moderate-certainty evidence), but probably results in little to no difference in rates of neonatal unit admission (RR 1.11, 95% CI 0.90 to 1.37; I² = 41%; 6 studies, 3560 participants; moderate-certainty evidence). Planned early birth may result in little to no difference in maternal death (RR 0.33, 95% CI 0.05 to 2.10; I² = 0%; 6 studies, 3491 participants; low-certainty evidence) or neonatal death (RR 1.40, 95% CI 0.45 to 4.35; I² not applicable; 5 studies, 3407 participants; low-certainty evidence). The evidence is very uncertain about the effect of planned early birth on composite perinatal mortality and morbidity due to high variation between the trials (RR 1.06, 95% CI 0.75 to 1.51; I² = 83%; 6 studies, 3576 participants; very low-certainty evidence). Five of the six trials included in this analysis were at low risk of bias. We graded the evidence as high, moderate, low, or very low certainty based upon GRADE criteria. Where we downgraded the evidence, it was typically due to higher levels of heterogeneity or due to imprecision, whereby the confidence interval crossed the line of both appreciable benefit and harm or the number of events was low. For women with hypertensive disorders of pregnancy beyond 34 weeks' gestation, planned early birth is associated with a lower risk of maternal complications, and probably a reduced risk of fetal death (stillbirth), with no increased risk of caesarean section and probably no clear differences in the rate of neonatal unit admission or short-term neonatal morbidity. It is important that the timing of delivery takes into account the woman's preferences, the type of hypertensive disorder and the presence or absence of severe features. Further information is needed to establish the longer-term infant outcomes associated with late preterm birth and longer-term maternal cardiovascular health. This Cochrane review had no dedicated funding. The original review and review protocol can be accessed via...
- 21 May 2026
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2026 (5) , CD009273
Planned early birth versus expectant management for hypertensive disorders from 34 weeks' gestation to term
Hypertensive disorders in pregnancy are significant contributors to maternal and perinatal morbidity and mortality. They include chronic hypertension, gestational hypertension and pre-eclampsia. Definitive management of these disorders is planned early birth. The alternative is expectant management with close monitoring, if severe complications are not present. There are benefits and risks associated with both policies, so it is important to establish the safest option. To assess the benefits and risks of planned early birth versus expectant management in pregnant women with hypertensive disorders, from 34 weeks' gestation onwards. An Information Specialist within the Cochrane Central Executive Team searched CENTRAL, MEDLINE, Embase, CINAHL, ClinicalTrials.gov and WHO ICTRP. The searches were run from 1 January 2016 to 16 January 2026 with no language restrictions. Reference lists of retrieved studies were also searched. We included randomised controlled trials comparing planned early birth (by induction of labour or by caesarean section) with expectant management for women with hypertensive disorders from 34 weeks' gestation. Cluster-randomised trials would have been eligible for inclusion in this review, but we found none. Studies using a quasi-randomised design were not eligible for inclusion in this review. Studies using a cross-over design were not eligible for inclusion, because they are not a suitable study design for investigating hypertensive disorders in pregnancy. The prespecified critical outcomes (based upon a core outcome set agreed via Delphi consensus) were (1) a composite outcome of maternal mortality and morbidity; (2) a composite outcome of perinatal mortality and morbidity; (3) maternal death; (4) fetal death; (5) neonatal death. The prespecified important maternal outcomes were: caesarean section, maternal admission to a high dependency unit, eclampsia, pulmonary oedema, severe renal impairment, and HELLP (haemolysis, elevated liver enzymes, low platelets) syndrome. The prespecified important perinatal outcome was neonatal unit admission. Additional maternal and perinatal outcomes were also analysed in accordance with the review protocol, including maternal quality of life measures and health resource use. Two review authors independently assessed risk of bias using the Cochrane Risk of Bias 2 (RoB 2) tool. The Cochrane trustworthiness screening tool was applied to all eligible studies at full-text review stage. Two review authors independently assessed eligibility and risk of bias. Two review authors independently extracted data using a prespecified data extraction form. Data were checked for accuracy. Statistical analysis was carried out in RevMan using a random-effects meta-analysis. We assessed the certainty of evidence using GRADE. We included six studies involving 3491 women. All six studies were randomised controlled trials evaluating planned early birth compared to expectant management. Planned early birth was evaluated at between 34 and 37 weeks in four studies, between 36 and 38 weeks in one study and between 36 and 41 weeks in one study. One study took place in low- and middle-income countries, whilst five took place in high-income countries. Three studies included only women with pre-eclampsia, two studies included women with a mixture of hypertensive disorders in pregnancy and one study included only women with chronic hypertension. Planned early birth reduces the risk of maternal mortality and morbidity compared to expectant management (RR 0.54, 95% CI 0.37 to 0.77; I² = 0%; 6 studies, 3491 participants; high-certainty evidence). There was no increased risk of caesarean section associated with planned early birth (RR 0.94, 95% CI 0.83 to 1.06; I² = 25%; 6 studies, 3539 participants; high-certainty evidence). Planned early birth likely results in a large reduction in the risk of stillbirth (fetal death) (RR 0.25, 95% CI 0.07 to 0.87; I² not applicable; 5 studies, 3407 participants; moderate-certainty evidence), but probably results in little to no difference in rates of neonatal unit admission (RR 1.11, 95% CI 0.90 to 1.37; I² = 41%; 6 studies, 3560 participants; moderate-certainty evidence). Planned early birth may result in little to no difference in maternal death (RR 0.33, 95% CI 0.05 to 2.10; I² = 0%; 6 studies, 3491 participants; low-certainty evidence) or neonatal death (RR 1.40, 95% CI 0.45 to 4.35; I² not applicable; 5 studies, 3407 participants; low-certainty evidence). The evidence is very uncertain about the effect of planned early birth on composite perinatal mortality and morbidity due to high variation between the trials (RR 1.06, 95% CI 0.75 to 1.51; I² = 83%; 6 studies, 3576 participants; very low-certainty evidence). Five of the six trials included in this analysis were at low risk of bias. We graded the evidence as high, moderate, low, or very low certainty based upon GRADE criteria. Where we downgraded the evidence, it was typically due to higher levels of heterogeneity or due to imprecision, whereby the confidence interval crossed the line of both appreciable benefit and harm or the number of events was low. For women with hypertensive disorders of pregnancy beyond 34 weeks' gestation, planned early birth is associated with a lower risk of maternal complications, and probably a reduced risk of fetal death (stillbirth), with no increased risk of caesarean section and probably no clear differences in the rate of neonatal unit admission or short-term neonatal morbidity. It is important that the timing of delivery takes into account the woman's preferences, the type of hypertensive disorder and the presence or absence of severe features. Further information is needed to establish the longer-term infant outcomes associated with late preterm birth and longer-term maternal cardiovascular health. This Cochrane review had no dedicated funding. The original review and review protocol can be accessed via...
- Top Cited PapersOpen Access
- 20 January 2026
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 133 (5) , 958-973
The Impact of Community‐Based Midwife Continuity of Care Models for Women Living in Areas of Social Disadvantage and Ethnic Diversity in the United Kingdom: A Prospective Cohort Study
Objective: Addressing inequalities in maternal and newborn health is a UK public health priority. Evidence on effective multi‐interventional strategies is urgently needed. This study evaluated the impact of community‐based midwife continuity of care (CBMCOC) models for women and babies in ethnically diverse and socially disadvantaged areas of South London. Design: We conducted a prospective cohort study using the eLIXIR, Born in South London, maternity–child data linkage. Setting: United Kingdom. Population: Pregnant women exposed to CBMCOC and standard care between 2018 and 2020. Methods: Propensity score matching (1:4) was used to account for differences between CBMCOC and standard care cohorts and control for confounding bias. Conditional logistic regression estimated risk ratios. Subgroup analysis included women of Black, Asian and other ethnic minority groups, and those living in highly deprived areas. Outcomes: The primary outcome was preterm birth (< 37 weeks' gestation). Secondary outcomes included other relevant maternal, perinatal, process and clinical variables. Results: Before matching, 12 386 women were exposed to standard care and 1338 to CBMCOC; after matching, 5352 and 1338 were included, respectively. The risk of preterm birth was lower among women exposed to CBMCOC (unmatched: 4.6% vs. 10.3%, RR = 0.50, 95% CI: 0.38–0.64; matched: 4.6% vs. 8.4%, RR = 0.54, 95% CI: 0.40–0.70). Subgroup analyses showed reduced preterm birth rates among ethnic minority women and those in deprived areas when exposed to CBMCOC. Conclusions: In this diverse population with a range of risk factors, locality‐based interventions integrating community‐based care and midwife continuity may reduce maternal and newborn health inequalities. Further trials of such models should be conducted.
- 20 January 2026
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 133 (5) , 958-973
Top Cited PapersOpen AccessThe Impact of Community‐Based Midwife Continuity of Care Models for Women Living in Areas of Social Disadvantage and Ethnic Diversity in the United Kingdom: A Prospective Cohort Study
Objective: Addressing inequalities in maternal and newborn health is a UK public health priority. Evidence on effective multi‐interventional strategies is urgently needed. This study evaluated the impact of community‐based midwife continuity of care (CBMCOC) models for women and babies in ethnically diverse and socially disadvantaged areas of South London. Design: We conducted a prospective cohort study using the eLIXIR, Born in South London, maternity–child data linkage. Setting: United Kingdom. Population: Pregnant women exposed to CBMCOC and standard care between 2018 and 2020. Methods: Propensity score matching (1:4) was used to account for differences between CBMCOC and standard care cohorts and control for confounding bias. Conditional logistic regression estimated risk ratios. Subgroup analysis included women of Black, Asian and other ethnic minority groups, and those living in highly deprived areas. Outcomes: The primary outcome was preterm birth (< 37 weeks' gestation). Secondary outcomes included other relevant maternal, perinatal, process and clinical variables. Results: Before matching, 12 386 women were exposed to standard care and 1338 to CBMCOC; after matching, 5352 and 1338 were included, respectively. The risk of preterm birth was lower among women exposed to CBMCOC (unmatched: 4.6% vs. 10.3%, RR = 0.50, 95% CI: 0.38–0.64; matched: 4.6% vs. 8.4%, RR = 0.54, 95% CI: 0.40–0.70). Subgroup analyses showed reduced preterm birth rates among ethnic minority women and those in deprived areas when exposed to CBMCOC. Conclusions: In this diverse population with a range of risk factors, locality‐based interventions integrating community‐based care and midwife continuity may reduce maternal and newborn health inequalities. Further trials of such models should be conducted.
- Open Access
- 1 October 2025
- Published by Wolters Kluwer Health in Hypertension
- Vol. 82 (10) , 1719-1728
Point-of-Care Placental Growth Factor for Predicting Adverse Outcomes in Sierra Leone
BACKGROUND: PlGF (placental growth factor) concentrations are lower in preeclampsia, a major cause of maternal death; testing improves diagnosis and outcomes. We evaluated 2 novel, whole blood, point-of-care PlGF tests (RONIA and Lepzi Quanti) in a low-resource setting for predicting adverse outcomes. METHODS: A prospective observational cohort study was conducted in women with hypertension in Sierra Leone, each of which were 24 to 36 +6 weeks of gestation. Eligible women underwent concealed RONIA and Lepzi Quanti PLGF testing. Optimal rule-out and rule-in thresholds were determined for predicting maternal (death and eclampsia) and perinatal (stillbirth, termination pre-viability, and neonatal death) composite outcomes. Sensitivity, specificity, negative predictive values, and positive predictive values were assessed. RESULTS: Analysis included women with RONIA (n=488) and Lepzi Quanti (n=140) PlGF tests. Optimal thresholds were >60 or >90 pg/mL (rule-out) and <20 or <12 pg/mL (rule-in) for RONIA and Lepzi Quanti, respectively. For tests <34 weeks, RONIA <60 pg/mL had high sensitivity and negative predictive value for ruling out maternal (94.9% and 94.6%) and perinatal (100%) composite outcomes. RONIA <20 pg/mL indicated higher risk (positive predictive values, 16.3% and 40.9% respectively). Lepzi Quanti <90 pg/mL had 100% sensitivity and negative predictive value for ruling out maternal and perinatal composites. Conversely, with Lepzi Quanti <12 pg/mL, nearly a quarter and a half of pregnancies experienced the maternal and perinatal composites (positive predictive values, 22.0% and 48.0%). Performance declined slightly at later gestations. CONCLUSIONS: Point-of-care PlGF testing shows accurate rule-out performance for serious outcomes, with potential for risk stratification in low-resource settings. For both tests, a minority of cases fell into an intermediate category, which would warrant increased surveillance to determine progress.
- 1 October 2025
- Published by Wolters Kluwer Health in Hypertension
- Vol. 82 (10) , 1719-1728
Open AccessPoint-of-Care Placental Growth Factor for Predicting Adverse Outcomes in Sierra Leone
BACKGROUND: PlGF (placental growth factor) concentrations are lower in preeclampsia, a major cause of maternal death; testing improves diagnosis and outcomes. We evaluated 2 novel, whole blood, point-of-care PlGF tests (RONIA and Lepzi Quanti) in a low-resource setting for predicting adverse outcomes. METHODS: A prospective observational cohort study was conducted in women with hypertension in Sierra Leone, each of which were 24 to 36 +6 weeks of gestation. Eligible women underwent concealed RONIA and Lepzi Quanti PLGF testing. Optimal rule-out and rule-in thresholds were determined for predicting maternal (death and eclampsia) and perinatal (stillbirth, termination pre-viability, and neonatal death) composite outcomes. Sensitivity, specificity, negative predictive values, and positive predictive values were assessed. RESULTS: Analysis included women with RONIA (n=488) and Lepzi Quanti (n=140) PlGF tests. Optimal thresholds were >60 or >90 pg/mL (rule-out) and <20 or <12 pg/mL (rule-in) for RONIA and Lepzi Quanti, respectively. For tests <34 weeks, RONIA <60 pg/mL had high sensitivity and negative predictive value for ruling out maternal (94.9% and 94.6%) and perinatal (100%) composite outcomes. RONIA <20 pg/mL indicated higher risk (positive predictive values, 16.3% and 40.9% respectively). Lepzi Quanti <90 pg/mL had 100% sensitivity and negative predictive value for ruling out maternal and perinatal composites. Conversely, with Lepzi Quanti <12 pg/mL, nearly a quarter and a half of pregnancies experienced the maternal and perinatal composites (positive predictive values, 22.0% and 48.0%). Performance declined slightly at later gestations. CONCLUSIONS: Point-of-care PlGF testing shows accurate rule-out performance for serious outcomes, with potential for risk stratification in low-resource settings. For both tests, a minority of cases fell into an intermediate category, which would warrant increased surveillance to determine progress.
- Open Access
- 18 June 2025
- Published by Elsevier in The Lancet
- Vol. 405 (10497) , 2302-2312
Community-based mentoring to reduce maternal and perinatal mortality in adolescent pregnancies in Sierra Leone (2YoungLives): a pilot cluster-randomised controlled trial
- 18 June 2025
- Published by Elsevier in The Lancet
- Vol. 405 (10497) , 2302-2312
Open AccessCommunity-based mentoring to reduce maternal and perinatal mortality in adolescent pregnancies in Sierra Leone (2YoungLives): a pilot cluster-randomised controlled trial
- Open Access
- 12 April 2024
- Published by International Society of Global Health in Journal of Global Health
- Vol. 14, 03019
Meaningful community engagement and involvement in global health and research: ‘Changing mindsets with a million conversations’ in Sierra Leone
Empowering and enabling communities to have control over decisions that affect their lives and giving them a genuine voice, is essential to achieving transformational impact and health for all, especially for the most disadvantaged, vulnerable and marginalised communities [1]. Much learning has been shared in recent years from a number of programmes and clinical trials […]
- 12 April 2024
- Published by International Society of Global Health in Journal of Global Health
- Vol. 14, 03019
Open AccessMeaningful community engagement and involvement in global health and research: ‘Changing mindsets with a million conversations’ in Sierra Leone
Empowering and enabling communities to have control over decisions that affect their lives and giving them a genuine voice, is essential to achieving transformational impact and health for all, especially for the most disadvantaged, vulnerable and marginalised communities [1]. Much learning has been shared in recent years from a number of programmes and clinical trials […]